Skip to main content

Articles

Page 39 of 70

  1. The results of treatment for malignant bone and soft-tissue tumors arising from the deep trunk and pelvis are still not acceptable due to the relatively high recurrence and low overall survival rates. Recently...

    Authors: Takashi Yanagawa, Kenichi Saito, Hiroki Kiyohara, Tatsuya Ohno, Takashi Nakano and Kenji Takagishi
    Citation: Radiation Oncology 2015 10:259
  2. Adjuvant radiotherapy (RT) of regional lymph nodes (LN) in early breast cancer is still a matter of debate. RT increases the Overall survival (OS) rate of breast cancer patients after breast conserving surgery...

    Authors: Wilfried Budach, Edwin Bölke, Kai Kammers, Peter Arne Gerber, Carolin Nestle-Krämling and Christiane Matuschek
    Citation: Radiation Oncology 2015 10:258
  3. The small bowel (SB) represents the most important dose-limiting structure in pelvic radiotherapy (RT). However, we observed that the majority of rectal cancer patients who received preoperative pelvic intensi...

    Authors: Benhua Xu, Yuyan Guo, Yuangui Chen, Haijie Lu, Tianlan Tang, Zhicao Yue, Guoxian Guan, Pan Chi and Chi Lin
    Citation: Radiation Oncology 2015 10:257
  4. Authors: Sandra Sarmento, Filipa Costa, Alexandre Pereira, Joana Lencart, Anabela Dias, Luís Cunha, Olga Sousa, José Pedro Silva and Lúcio Santos
    Citation: Radiation Oncology 2015 10:256

    The original article was published in Radiation Oncology 2015 10:7

  5. Radio-chemotherapy is one of the steps of multidisciplinary management in locally advanced pancreatic cancer. The Epidermal Growth Factor Receptor (EGFR) plays an important role in the disease pathway. The pur...

    Authors: Michele Fiore, Lucio Trodella, Sergio Valeri, Domenico Borzomati, Barnaba Floreno, Edy Ippolito, Pasquale Trecca, Luca Eolo Trodella, Rolando Maria D’Angelillo, Sara Ramella and Roberto Coppola
    Citation: Radiation Oncology 2015 10:255
  6. Registering CTs for patients receiving external beam radiotherapy (EBRT) with a boost dose from high-dose-rate brachytherapy (HDR) can be challenging due to considerable image discrepancies (e.g. rectal fillin...

    Authors: Calyn R. Moulton, Michael J. House, Victoria Lye, Colin I. Tang, Michele Krawiec, David J. Joseph, James W. Denham and Martin A. Ebert
    Citation: Radiation Oncology 2015 10:254
  7. Whole brain radiotherapy (WBRT) has been the treatment of choice for patients with brain metastases. However, change/decline of neurocognitive functions (NCFs) resulting from impaired hippocampal neurogenesis ...

    Authors: Ping-Fang Tsai, Chi-Cheng Yang, Chi-Cheng Chuang, Ting-Yi Huang, Yi-Ming Wu, Ping-Ching Pai, Chen-Kan Tseng, Tung-Ho Wu, Yi-Liang Shen and Shinn-Yn Lin
    Citation: Radiation Oncology 2015 10:253
  8. Cervical cancer is associated with a high yearly mortality. The presence of persistent disease after radiotherapy is a significant predictor of patient survival.

    Authors: J. E. Mongula, B. F. M. Slangen, D. M. J. Lambregts, F. Cellini, F. C. H. Bakers, L. C. H. W. Lutgens, T. Van Gorp, A.J. Kruse, R. F. P. M. Kruitwagen and R. G. H. Beets-Tan
    Citation: Radiation Oncology 2015 10:252
  9. To report our long-term results with postoperative intensity-modulated radiation therapy (IMRT) in patients suffering from squamous-cell carcinoma (SCC) of the oral cavity or oropharynx.

    Authors: M. Hoffmann, L. Saleh-Ebrahimi, F. Zwicker, P. Haering, A. Schwahofer, J. Debus, P.E. Huber and F. Roeder
    Citation: Radiation Oncology 2015 10:251
  10. Elderly patients with non-small cell lung cancer (NSCLC) are frequently treated with radiation therapy (RT) alone, due to poor performance status or underlying disease. We investigated the effectiveness of RT ...

    Authors: Ji Hyeon Joo, Si Yeol Song, Su Ssan Kim, Yuri Jeong, Seong-Yun Jeong, Wonsik Choi and Eun Kyung Choi
    Citation: Radiation Oncology 2015 10:250
  11. The purpose of this study was to assess the impact on dose to the planning target volume (PTV) and organs at risk (OAR) by using four differently generated CT datasets for dose calculation in stereotactic body...

    Authors: Markus Oechsner, Leonhard Odersky, Johannes Berndt, Stephanie Elisabeth Combs, Jan Jakob Wilkens and Marciana Nona Duma
    Citation: Radiation Oncology 2015 10:249
  12. Stereotactic radiosurgery (SRS) alone is an increasingly common treatment strategy for brain metastases. However, existing prognostic tools for overall survival (OS) were developed using cohorts of patients tr...

    Authors: Imran H. Chowdhury, Eric Ojerholm, Matthew T. McMillan, Denise Miller, James D. Kolker, Goldie Kurtz, Jay F. Dorsey, Suneel N. Nagda, Geoffrey A. Geiger, Steven Brem, Donald M. O’Rourke, Eric L. Zager, Tara Gangadhar, Lynn Schuchter, John Y. K. Lee and Michelle Alonso-Basanta
    Citation: Radiation Oncology 2015 10:248
  13. The relationship between ERCC2 polymorphisms and the risk of radiotoxicity remains inconclusive. The aim of our study is to systematically evaluate the association between ERCC2 polymorphisms and the risk of r...

    Authors: Yu-Zhe Song, Mei-Na Duan, Yu-Yu Zhang, Wei-Yan Shi, Cheng-Cheng Xia and Li-Hua Dong
    Citation: Radiation Oncology 2015 10:247
  14. Plan adaptation during the course of (chemo)radiotherapy of H&N cancer requires repeat CT scanning to capture anatomy changes such as parotid gland shrinkage. Hydration, applied to prevent nephrotoxicity from ...

    Authors: Petronella M. Kager, Sanne C. C. van Weerdenburg, Simon R. van Kranen, Suzanne van Beek, Elisabeth A. Lamers-Kuijper, Wilma D. Heemsbergen, Olga Hamming-Vrieze and Peter Remeijer
    Citation: Radiation Oncology 2015 10:246
  15. Whole brain radiation therapy (WBRT) is widely used for the treatment of brain metastases. Cognitive decline and alopecia are recognized adverse effects of WBRT. Recently hippocampus sparing whole brain radiat...

    Authors: Anand Mahadevan, Carrie Sampson, Salvatore LaRosa, Scott R. Floyd, Eric T. Wong, Erik J. Uhlmann, Soma Sengupta and Ekkehard M. Kasper
    Citation: Radiation Oncology 2015 10:245
  16. Our purpose was to analyze the long-term clinical outcome and to identify prognostic factors after Linac-based stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT) on patients with ...

    Authors: David Kaul, Alexander Angelidis, Volker Budach, Pirus Ghadjar, Markus Kufeld and Harun Badakhshi
    Citation: Radiation Oncology 2015 10:244
  17. A prospective clinical trial was conducted to evaluate the feasibility of a novel approach to the treatment of patients with high risk prostate cancer (HRPC) through the use of a nomogram to tailor radiotherap...

    Authors: Raymond Wu, Hannah Woodford, Anne Capp, Perry Hunter, Gary Cowin, Keen-Hun Tai, Paul L. Nguyen, Peter Chong and Jarad Martin
    Citation: Radiation Oncology 2015 10:243
  18. To report on the acute toxicity in children with medulloblastoma undergoing intensity-modulated radiation therapy (IMRT) with daily intrafractionally modulated junctions.

    Authors: Maurice C. Cox, Johannes M. Kusters, Corrie E. Gidding, Jolanda H. Schieving, Erik J. van Lindert, Johannes H. Kaanders and Geert O. Janssens
    Citation: Radiation Oncology 2015 10:241
  19. Standard dose of external beam radiotherapy seems to be insufficient for satisfactory control of loco-regionally advanced cervical cancer. Aim of our study is to evaluate the outcome as well as early and chron...

    Authors: Nikola Cihoric, Alexandros Tsikkinis, Coya Tapia, Daniel M. Aebersold, Inti Zlobec and Kristina Lössl
    Citation: Radiation Oncology 2015 10:240
  20. Magnetic resonance imaging (MRI) has been incorporated as an adjunct to CT to take advantage of its excellent soft tissue contrast for contouring. MR-only treatment planning approaches have been developed to a...

    Authors: Joshua Kim, Kim Garbarino, Lonni Schultz, Kenneth Levin, Benjamin Movsas, M. Salim Siddiqui, Indrin J. Chetty and Carri Glide-Hurst
    Citation: Radiation Oncology 2015 10:239
  21. Limited data describe the prognosis after stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer. Thus, we evaluated treatment outcomes of stereotactic ablative radiotherapy for ...

    Authors: Jinhong Jung, Si Yeol Song, Jong Hoon Kim, Chang Sik Yu, Jin Cheon Kim, Tae Won Kim, Seong-Yun Jeong, Su Ssan Kim and Eun Kyung Choi
    Citation: Radiation Oncology 2015 10:238
  22. The aim of the thesis is to improve radiation plans of patients with locally advanced, unresectable pancreatic cancer by using carbon ion and proton beams.

    Authors: Constantin Dreher, Daniel Habermehl, Swantje Ecker, Stephan Brons, Rami El-Shafie, Oliver Jäkel, Jürgen Debus and Stephanie E. Combs
    Citation: Radiation Oncology 2015 10:237
  23. Using radiobiological modelling to estimate normal tissue toxicity, this study investigates the effects of dose escalation for concurrent chemoradiation therapy (CRT) in lower third oesophageal tumours on the ...

    Authors: Rhys Carrington, John Staffurth, Samantha Warren, Mike Partridge, Chris Hurt, Emiliano Spezi, Sarah Gwynne, Maria A. Hawkins and Thomas Crosby
    Citation: Radiation Oncology 2015 10:236
  24. The purpose of this study was to investigate the role of beam collimator rotation in Volumetric Modulated Arc Therapy (VMAT) for craniospinal irradiation (CSI), and the impact on dose distribution in the beam ...

    Authors: Qilin Li, Wendong Gu, Jinming Mu, Wenming Yin, Min Gao, Juncong Mo and Honglei Pei
    Citation: Radiation Oncology 2015 10:235
  25. Treatment plan quality assurance (QA) is important for clinical studies and for institutions aiming to generate near-optimal individualized treatment plans. However, determining how good a given plan is for th...

    Authors: Jim P. Tol, Max Dahele, Alexander R. Delaney, Ben J. Slotman and Wilko F. A. R. Verbakel
    Citation: Radiation Oncology 2015 10:234
  26. The most appropriate treatment for men with prostate cancer and positive pelvic nodes, N+, is an area of active controversy. We report our 5-years outcomes in men with locally advanced prostate cancer (T1-T4N0...

    Authors: Wolfgang Lilleby, Amol Narrang, Gunnar Tafjord, Ljiljana Vlatkovic, Kjell Magne Russnes, Andreas Stensvold, Knut HÃ¥kon Hole, Phuoc Tran and Karsten Eilertsen
    Citation: Radiation Oncology 2015 10:232
  27. This study compared VMAT and IMRT plans for intact breast radiotherapy for left sided breast cancer and evaluated the irradiated dose of planning target volume and OARs, especially focusing on heart and corona...

    Authors: Hongfu Zhao, Mingyuan He, Guanghui Cheng, Dongmei Han, Ning Wu, Dan Shi, Zhipeng Zhao and Jianxue Jin
    Citation: Radiation Oncology 2015 10:231
  28. Tumour hypoxia promotes radioresistance and is associated with poor prognosis. The transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT), also designated as Hypoxia-inducible factor (HIF)-...

    Authors: Markus Mandl, Maria- Katharina Lieberum, Juergen Dunst and Reinhard Depping
    Citation: Radiation Oncology 2015 10:229
  29. The incidence and associated factors of loose seed migration were investigated in cohort 1 of the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS).

    Authors: Masahiro Nakano, Atsunori Yorozu, Shiro Saito, Akitomo Sugawara, Shinichiroh Maruo, Shinsuke Kojima, Takashi Kikuchi, Masanori Fukushima, Takushi Dokiya and Hidetoshi Yamanaka
    Citation: Radiation Oncology 2015 10:228
  30. Local tumor control by standard fractionated radiotherapy (RT) remains poor because of tumor resistance to radiation (radioresistance). It has been suggested that cancer stem cells (CSCs) are more radioresista...

    Authors: Yuhchyau Chen, Fuquan Zhang, Ying Tsai, Xiadong Yang, Li Yang, Shanzhou Duan, Xin Wang, Peter Keng and Soo Ok Lee
    Citation: Radiation Oncology 2015 10:227
  31. This study evaluated an automated inverse treatment planning algorithm, Pinnacle Auto-Planning (AP), and compared automatically generated plans with historical plans in a large cohort of head and neck cancer p...

    Authors: Jerome Krayenbuehl, Ian Norton, Gabriela Studer and Matthias Guckenberger
    Citation: Radiation Oncology 2015 10:226
  32. Our previous data demonstrated that targeting non-homologous end-joining repair (NHEJR) yields a higher radiosensitivity than targeting homologous recombination repair (HRR) to heavy ions using DNA repair gene...

    Authors: Hongyu Ma, Akihisa Takahashi, Yukari Yoshida, Akiko Adachi, Tatsuaki Kanai, Tatsuya Ohno and Takashi Nakano
    Citation: Radiation Oncology 2015 10:225
  33. Shortening the overall treatment time without increasing acute reactions is one of the major aims in radiotherapy for head and neck cancer (HNC). Volumetric modulated arc therapy (VMAT) with Simultaneous Integ...

    Authors: Ciro Franzese, Antonella Fogliata, Elena Clerici, Davide Franceschini, Elisa Villa, Giuseppe D’Agostino, Piera Navarria, Pietro Mancosu, Stefano Tomatis, Luca Cozzi and Marta Scorsetti
    Citation: Radiation Oncology 2015 10:224
  34. Colony formation assay is the gold standard to determine cell reproductive death after treatment with ionizing radiation, applied for different cell lines or in combination with other treatment modalities. Ass...

    Authors: Herbert Braselmann, Agata Michna, Julia Heß and Kristian Unger
    Citation: Radiation Oncology 2015 10:223
  35. Dexamethasone (DXM) is commonly used in the management of cerebral edema in patients diagnosed with glioblastoma multiforme (GBM). Bevacizumab (BEV) is FDA-approved for the progression or recurrence of GBM but...

    Authors: Lisa B. E. Shields, Brent J. Shelton, Andrew J. Shearer, Li Chen, David A. Sun, Sarah Parsons, T. David Bourne, Renato LaRocca and Aaron C. Spalding
    Citation: Radiation Oncology 2015 10:222
  36. Stereotactic radiosurgery (SRS) is an alternative to post-operative whole brain radiation therapy (WBRT) following resection of brain metastases. At our institution, CyberKnife (CK) is considered for local tre...

    Authors: Jennifer Vogel, Eric Ojerholm, Andrew Hollander, Cynthia Briola, Rob Mooij, Michael Bieda, James Kolker, Suneel Nagda, Geoffrey Geiger, Jay Dorsey, Robert Lustig, Donald M. O’Rourke, Steven Brem, John Lee and Michelle Alonso-Basanta
    Citation: Radiation Oncology 2015 10:221
  37. To evaluate the performance of a broad scope model-based optimisation process for volumetric modulated arc therapy applied to esophageal cancer.

    Authors: Antonella Fogliata, Giorgia Nicolini, Alessandro Clivio, Eugenio Vanetti, Sarbani Laksar, Angelo Tozzi, Marta Scorsetti and Luca Cozzi
    Citation: Radiation Oncology 2015 10:220
  38. Radiotherapy is associated with a risk of subsequent neoplasms (SN) in childhood cancer survivors. It has been shown that children’s thyroid glands are especially susceptible. The aim is to quantify the risk o...

    Authors: Isabelle Finke, Peter Scholz-Kreisel, Ulrike Hennewig, Maria Blettner and Claudia Spix
    Citation: Radiation Oncology 2015 10:219
  39. We report the radiographic response rate of SBRT compared to conventional fractionated radiotherapy (CF-EBRT) for thoracic, abdominal, skin and soft tissue RCC lesions treated at our institution.

    Authors: Basel Altoos, Arya Amini, Muthanna Yacoub, Maria T. Bourlon, Elizabeth E. Kessler, Thomas W. Flaig, Christine M. Fisher, Brian D. Kavanagh, Elaine T. Lam and Sana D. Karam
    Citation: Radiation Oncology 2015 10:218
  40. The patient positioning in pelvic radiotherapy (RT) should be decided based on both reproducibility and on which position that yields the lowest radiation dose to the organs at risk (OAR), and thereby less sid...

    Authors: Trude C. Frøseth, Trond Strickert, Kjersti S. Solli, Øyvind Salvesen, Gunilla Frykholm and Randi J. Reidunsdatter
    Citation: Radiation Oncology 2015 10:217
  41. Achieving durable local control while limiting normal tissue toxicity with definitive radiation therapy in the management of high-risk brain metastases remains a radiobiological challenge. The objective of thi...

    Authors: Jonathan W. Lischalk, Eric Oermann, Sean P. Collins, Mani N. Nair, Vikram V. Nayar, Richa Bhasin, Jean-Marc Voyadzis, Sonali Rudra, Keith Unger and Brian T. Collins
    Citation: Radiation Oncology 2015 10:216
  42. The use of a tissue expander (hydrogel) for sparing of the rectum from increased irradiation during prostate radiotherapy is becoming popular. The goal of this study is to investigate the effect of a tissue ex...

    Authors: Prabhjot Juneja, Andrew Kneebone, Jeremy T. Booth, David I. Thwaites, Ramandeep Kaur, Emma Colvill, Jin A. Ng, Paul J. Keall and Thomas Eade
    Citation: Radiation Oncology 2015 10:215
  43. The mitogen-activated protein kinases (MAPK) and the phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathways are intertwined on various levels and simultaneous inhibition reduces tum...

    Authors: Sebastian Kuger, Michael Flentje and Cholpon S. Djuzenova
    Citation: Radiation Oncology 2015 10:214
  44. Exploiting biologic imaging, studies have been performed to boost dose to gross intraprostatic tumor volumes (GTV) while reducing dose elsewhere in the prostate. Interest in proton beams has increased due to s...

    Authors: Inhwan Yeo, Prashanth Nookala, Ian Gordon, Reinhard Schulte, Stanley Barnes, Abiel Ghebremedhin, Ning Wang, Gary Yang, Ted Ling, David Bush, Jerry Slater and Baldev Patyal
    Citation: Radiation Oncology 2015 10:213
  45. We conducted a retrospective analysis on 884 patients who were diagnosed with esophageal squamous cell carcinoma (ESCC) and treated with either the neutron brachytherapy in combination with external beam radio...

    Authors: Qifeng Wang, Tao Li, Jinyi Lang, Jie Wang, Jian Wang, Huiming Liu, Xitang Jia, Bo Liu and C-K Chris Wang
    Citation: Radiation Oncology 2015 10:212
  46. The hippocampus is considered as the main radiosensitive brain structure responsible for postradiotherapy cognitive decline. We prospectively assessed correlation of memory change to hippocampal N-acetylaspart...

    Authors: Petr Pospisil, Tomas Kazda, Martin Bulik, Marie Dobiaskova, Petr Burkon, Ludmila Hynkova, Pavel Slampa and Radim Jancalek
    Citation: Radiation Oncology 2015 10:211
  47. This study aimed to elucidate the influence of skin invasion in patients with recurrent head and neck cancer treated with re-irradiation using stereotactic radiotherapy.

    Authors: Hideya Yamazaki, Mikio Ogita, Kengo Himei, Satoaki Nakamura, Gen Suzuki, Tadayuki Kotsuma, Ken Yoshida and Yasuo Yoshioka
    Citation: Radiation Oncology 2015 10:210

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions